Watch out for the below mentioned stocks in news which are likely to be on spotlight for today the 16-Jan-2026 : - Infosys - The IT solutions player reported a 2.2 per cent YoY fall in the net profit at Rs 6,654 crore, while revenue in rupee terms grew 8.9 per cent YoY to Rs 45,479 crore for the quarter ended on December 31, 2025. Ebit rose 6.5 per cent YoY to Rs 9,479 crore, while Ebit margins fell to 20.8 per cent for the quarter. Dr Reddy's Laboratories - The pharma major announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution, the generic equivalent of Extra Strength Pataday Once-Daily Relief, in the US market, as approved by the USFDA. Jio Financial Services - The RIL-backed financial services player's net profit fell 8.75 per cent YoY to Rs 268.98 crore, while total income rose 10.7 per cent YoY to Rs 901.05 crore for the Q3FY26. Pre-provisioning operating grew 7 per cent YoY to Rs 354 crore, while its AUM zoomed 4.5 times to Rs 19,049 crore. Zydus Lifesciences - The pharma company has received final approval from the USFDA for Eltrombopag tablets, which are used for the treatment of thrombocytopenia in specific blood disorders. Eltrombopag tablets had annual sales of $1,262.5 million in the United States. It has completed the acquisition of Agenus Inc.’s biologics manufacturing facilities and launched Zylidac Bio.

INFY

DRREDDY

JIOFIN

ZYDUSLIFE

#WatchOutFor#StockInNews#FundamentalViews#PsychologyofMoney#EquityResearch

1,030 likes·69 comments